急性冠脉综合征患者使用比伐卢定加用高剂量输注与肝素的对比研究 - Suppr

Suppr

超能文献

Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome.

作者信息

Galli Mattia, Gargiulo Giuseppe, Benenati Stefano, Mehran Roxana, Angiolillo Dominick J

机构信息

Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, 48033 Cotignola, Ravenna, Italy.

Department of Advanced Biomedical Sciences, University Federico II of Naples, Corso Umberto I 40, 80138 Naples, Italy.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):666-668. doi: 10.1093/ehjcvp/pvad029.

DOI:10.1093/ehjcvp/pvad029

PMID:37081774

Abstract

摘要

相似文献

Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome.

Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):666-668. doi: 10.1093/ehjcvp/pvad029.

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.

Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25.

Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators).

Am J Cardiol. 2010 Oct 1;106(7):941-5. doi: 10.1016/j.amjcard.2010.06.003. Epub 2010 Aug 17.

Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.

Circ Cardiovasc Interv. 2012 Oct;5(5):705-12. doi: 10.1161/CIRCINTERVENTIONS.112.972869. Epub 2012 Oct 9.

Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

JACC Cardiovasc Interv. 2008 Dec;1(6):639-48. doi: 10.1016/j.jcin.2008.10.004.

Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART.

Eur Heart J Acute Cardiovasc Care. 2019 Sep;8(6):510-519. doi: 10.1177/2048872618817217. Epub 2019 Jun 25.

Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.

Circ Cardiovasc Interv. 2014 Jun;7(3):365-73. doi: 10.1161/CIRCINTERVENTIONS.113.001126. Epub 2014 Apr 15.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

N Engl J Med. 2015 Sep 10;373(11):997-1009. doi: 10.1056/NEJMoa1507854. Epub 2015 Sep 1.

Comparison of Safety and Efficacy of Unfractionated Heparin Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention.

Heart Lung Circ. 2017 Dec;26(12):1277-1281. doi: 10.1016/j.hlc.2016.12.019. Epub 2017 Feb 28.

Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes.

Int J Cardiol. 2016 Oct 1;220:496-500. doi: 10.1016/j.ijcard.2016.06.247. Epub 2016 Jun 28.

引用本文的文献

Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

BMC Cardiovasc Disord. 2024 Dec 19;24(1):713. doi: 10.1186/s12872-024-04399-5.

Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.

BMC Med. 2024 Sep 27;22(1):410. doi: 10.1186/s12916-024-03579-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验